Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents
Masakazu Fukushima, Kenzo Iizuka, Cheng Jin, Chun Zhang, Mei Hong, Kiyoshi Eshima Division of Oncology Research and Development, Delta-Fly Pharma Inc., Kawauchi-cho, Tokushima, Japan Abstract: To reduce 5-fluorouracil (5-FU)-induced serious toxicities without loss of antitumor activity, we have deve...
Saved in:
Main Authors: | Fukushima M (Author), Iizuka K (Author), Jin C (Author), Zhang C (Author), Hong M (Author), Eshima K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model
by: Iizuka K, et al.
Published: (2018) -
Needle Revision with Antimetabolites in Bleb Failure
by: Ehab Ghoneim
Published: (2014) -
An easy and safe method of subconjunctival injection of antimetabolites in glaucoma surgery
by: Sergey N. Svetozarskiy, et al.
Published: (2023) -
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
by: Yixin Chen, et al.
Published: (2023) -
Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
by: Federica De Castro, et al.
Published: (2023)